Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase membrane subunit k (ATP5MK) is a small, highly conserved protein within the F₀ subunit of the mitochondrial ATP synthase complex that is embedded in the inner mitochondrial membrane. ATP synthase is a large multimeric enzyme responsible for synthesizing ATP from ADP and inorganic phosphate during oxidative phosphorylation. Subunit k (also known as DAPIT) is involved in the assembly, stability, and structural integrity of the ATP synthase complex, including the formation of ATP synthase dimers that are essential for proper cristae morphology in mitochondria. Dysregulation or mutation of ATP5MK/DAPIT has been associated with altered energy metabolism and implicated in certain pathologies, including diabetes and muscular disorders. Although subunit k itself is not currently a direct therapeutic target, its role in disease mechanisms and as a potential biomarker is of growing research interest[2][3][4].
Not established for subunit k alone For the entire ATP synthase complex: inhibitors bind F₀ sector and block proton translocation, inhibiting ATP synthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase membrane subunit k, mitochondrial (ATP5MK).